本发明还涉及含有结构式(I)的天冬氨酸蛋白酶抑制剂的药物组合物。
The present invention is also directed to pharmaceutical compositions comprising the aspartic protease inhibitors of Structural Formula (I).
本发明涉及由右述结构式(I)表示的天冬氨酸蛋白酶抑制剂或其药学上可接受的盐。
The present invention relates to aspartic protease inhibitors represented by the following structural formula (I), or a pharmaceutically acceptable salt thereof.
天冬氨酸蛋白酶在氨态氮和游离氨基酸的形成过程中，贡献率最小；在将蛋白水解成肽氮的过程中，天冬氨酸蛋白酶和半胱氨酸蛋白酶起到了主要作用。
Aspartic peptidase made little contribution on the formation of NH3-N and AA-N. degradation of protein into peptides was attributed to aspartic-and cysteine peptidases.
将自制蛋白酶以5%的量水解下脚料，纸层析表明产物中含谷氨酸、天冬氨酸等鲜味氨基酸。
Hydrolyzing the discarded material with 5% neutral proteinase we make, the paper chromatography indicated that the hydrolysate contained glutamic acid and aspartic acid.
将自制蛋白酶以5%的量水解下脚料，纸层析表明产物中含谷氨酸、天冬氨酸等鲜味氨基酸。
Hydrolyzing the discarded material with 5% neutral proteinase we make, the paper chromatography indicated that the hydrolysate contained glutamic acid and aspartic acid.
应用推荐